The Canadian Press

2015-10-26 | Valeant

Preview Clip

$149.00
The CEO of Valeant Pharmaceuticals is asking US securities regulators to investigate Citron Research, which has cast questions over the business practices of the Quebec-based company. Michael Pearson told analysts on a conference call this morning the company is the victim of false allegations by outsiders who want to manipulate the market for their own profit. (Left compared Valeant to Enron, the American energy firm that collapsed after widespread deception and fraud at the highest levels of management and alleged that Valeant set up a network of phantom pharmacies to fool auditors.)

Date: 2015-10-26
Placeline: MONTREAL.
Source: The Canadian Press
Length: 23 seconds

Transcript Prediction: << does Sensational claims made by the short-seller Andrew left through his entity Citron are completely untrue is motivation is the same as someone who runs into a crowded theater to falsely yell fire he wanted people to run intentionally designed the report to frighten our shareholders to drive down the price of our stock so he can make money for short selling >>


Earbank_2015-10-26_Valeant_7940